MAPK3 and head and neck squamous cell carcinoma: In the case of head and neck squamous cell carcinoma (HNSCC) cells, a comparative analysis of CD44+ cells (indicator of stemness) and control CD44(−) cells revealed that Nanog or ERK1/2 was highly expressed in CD44+ cells.